Mitosol 0.2 MG kits
Ended Awarded
- Contract number
- SPE2DB25FZG09
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,790
Award facts
- Contract value 100% obligated
- $15,789.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $15,789.60 to DMS Pharmaceutical Group Inc. for Mitosol 0.2 mg kits. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order at its facility in Park Ridge. The award was issued on May 12, 2025, with an ultimate completion date of June 3, 2025, and carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026, which authorizes the agency to issue firm fixed-price orders for a comprehensive range of pharmaceutical products supporting military healthcare facilities.
Mitosol (mitomycin C) is a chemotherapy agent commonly used in ophthalmologic and oncologic applications. As an established supplier in the federal pharmaceutical supply chain since 2001, DMS Pharmaceutical Group has demonstrated consistent capability in delivering specialized pharmaceutical products to Department of Defense healthcare sites nationwide. The company's track record includes distribution of complex medications spanning contraceptive devices, oncology treatments, and various prescription drugs to military medical facilities. This delivery order represents routine procurement activity within DMS Pharmaceutical Group's broader pharmaceutical distribution mission to support federal healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FZG09?
SPE2DB25FZG09 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on May 12, 2025.
How much is contract SPE2DB25FZG09 worth?
The government has obligated $15,790 on SPE2DB25FZG09.
Is contract SPE2DB25FZG09 an order under another contract?
Yes. SPE2DB25FZG09 is a delivery order under SPE2DB22D9205, an indefinite delivery contract.
Was contract SPE2DB25FZG09 competed?
The extent of competition for SPE2DB25FZG09 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award